N.Y. AG sets sights on Forest trials
Executive Summary
New York Attorney General Eliot Spitzer issues a request to Forest for information related to off-label clinical trials and promotion of its products, company says June 29. The AG is "concerned that Forest may be in violation of New York state law"; Forest maintains it has been in compliance with all applicable laws. Spitzer recently brought suit against GlaxoSmithKline, alleging the company concealed results from pediatric studies of its antidepressant Paxil (1"The Pink Sheet" June 7, 2004, p. 3). Forest issued a press release reiterating the results of Celexa and Lexapro pediatric studies after the Paxil suit was filed (2"The Pink Sheet" June 28, 2004, p. 30)...